May 10, 2021 | Featured, Federal Issues, Podcast
On this episode of the podcast, Terry and Bob discuss the threats posed by H.R. 3, prescription drug price control legislation that was reintroduced in the House of Representatives in April. They point out how the Covid-19 vaccine demonstrates the importance of...
Read more
May 1, 2021 | Featured, Podcast
S2:EP17 | Organ Transplants and Financial Strain On this episode of the podcast, Terry and Bob discuss the hurdles that organ recipients face, particularly in their postoperative treatment, which requires them to relocate close to the specialized medical centers...
Read more
Apr 19, 2021 | Featured, Federal Issues, Podcast
On this episode of the podcast, Terry and Bob discuss the recent recommendations by the Medicaid and CHIP Payment and Access Commission (MACPAC) that threaten patient access to medications that have received the FDA’s accelerated approval designation. These...
Read more
Apr 11, 2021 | Featured, Issues, Podcast
On this episode of the podcast, Terry and Bob discuss the numerous cost-drivers that inflate the price of American healthcare. They highlight how electronic health records requirements divert doctors’ attention away from patients to unproductive bureaucratic...
Read more
Apr 5, 2021 | Featured, Podcast
On this episode of the podcast, Terry and Bob discuss the latest developments in access to treatments for lupus patients. They highlight how ICER’s recent review of lupus treatments threatens access for patients because it inherently underestimates the value of...
Read more
Mar 27, 2021 | Featured, Podcast
On this episode of the podcast, Terry and Bob discuss ICER’s pending reports on two medications to treat the most severe form of lupus. They worry that ICER’s pattern of undervaluing medicines for patients with rare and chronic diseases will continue with...
Read more
